Physician
Tyler James Willenbrink, M.D.
According to 2025 Medicare claims, Tyler Willenbrink, M.D. (NPI: 1306367396) practices dermatology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is ZITELLI & BRODLAND PC (NPI: 1184790099; TIN: 251549973) and primary practice location at 15146-2836.
Willenbrink's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 378 traditional Medicare patients, billed 1,804 HCPCS/CPT codes, and received $403,837 in Medicare payments. The top billing code was 17313 (Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks). Part D data shows 114 prescription claims across 83 beneficiaries totaling $2,826 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 2 records totaling $233. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $590 to $2,826. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.